Category:
Carcinomas
Cancer type:
Prostate
Descriptor:
Poor Prognosis
Reference Number:
386
Hashem M, Essam T. Hepatocyte growth factor as a tumor marker in the serum of patients with prostate cancer.
J Egypt Natl Canc Inst. 17, 114-20 (2005)
PubMed link
Reference Number:
475
Humphrey PA, Halabi S, Picus J, Sanford B, Vogelzang NJ, Small EJ, Kantoff PW. Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone- refractory prostate cancer: results from cancer and leukemia group B 150005/9480.
Clin Genitourin Cancer. 4, 269-74 (2006)
PubMed link
Reference Number:
538
Verras M, Lee J, Xue H, Li TH, Wang Y, Sun Z. The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression.
Cancer Res.
67, 967-75 2007
PubMed link
